The Second Annual Texas Medical Center Hispanic Transplant Symposium on Sept. 26 drew doctors, nurses, researchers, clinicians, dieticians, organ donation and transplantation professionals and patients to discuss the challenges facing the Hispanic population in the United States when it comes to receiving care for end-stage organ disease.
“Forty percent of people on the waiting list in Texas identify themselves as Hispanic,” said Mark Hobeika, M.D., a transplant surgeon at Memorial Hermann-Texas Medical Center and McGovern Medical School at UTHealth and the symposium chair and master of ceremonies. “We, as members of the organ donation and transplant community, should be at the forefront of providing culturally appropriate care for the Hispanic population.”
In addition to being genetically predisposed to developing end-stage renal disease, Hispanics also face other issues that keep them from receiving appropriate medical care, according to keynote speaker, Sylvia E. Rosas, M.D., a nephrologist and director of the Latino Kidney Clinic at Joslin Diabetes Center and Beth Israel Deaconess Hospital, and associate professor of medicine at Harvard Medical School.
“Minorities take longer, A) to be referred to a doctor and, B) to do the work-up,” Rosas said. “It could be they don’t have insurance. They may not have access to transportation, can’t take off work. They may not believe in getting a transplant.”
Rosas has worked closely with the Kidney Allocation System (KAS) to even out the playing field for minorities waiting on life-saving kidney transplants.
“Before KAS, the time on the waiting list was done after you were waitlisted for an organ,” Rosas said. “Now with KAS, the time that you are put on the list starts when you start dialysis,” Rosas said. “Traditionally, minorities took longer to get waitlisted. For example, it took them two or three years on dialysis plus the four or five years it takes to get an organ transplant versus whites who may have been listed even before they needed dialysis. The KAS system makes it so the start of dialysis is the start of the list for everyone now.”
But it is not just genetics and logistics that keep the Hispanic population from receiving the medical care they need. Many speakers at the symposium noted that organ donation and transplantation go against fundamental beliefs of some members of the community.
With the second-largest Hispanic population in the United States, Houston health care professionals agree that a culturally-sensitive approach to working with the Hispanic population will be essential in moving forward with lowering rates of end-stage organ disease.
“This gives those of us in the organ donation and transplantation community an opportunity to work on a huge problem that we have, which is to get more patients transplants within the Hispanic community,” said LifeGift president and CEO, Kevin Myer. “There are social, cultural, financial and access challenges and by having this symposium together, we can narrow those down. Hopefully, the sharing of knowledge will allow us to be more effective in increasing donation and transplantation within the Hispanic community in Houston and across the U.S.”
MD Anderson Cancer Center@MDAndersonNews
How we’re using #immunotherapy to control blood cancers: https://t.co/7tDWZsHvo1 #CancerMoonshot #endcancer https://t.co/J2zcXMjsE1
Baylor College of MedicineBaylorCollegeOfMedicine
Congratulations to Dr. Xiang Zhang on being the 2018 Sue Eccles Young Investigator Award recipient from the Metastasis Research Society. #research #awards
Start off your morning on a tropical note with our Sugar, Heart, and Life Program's mango shake! https://t.co/TQxtiWD5yO
New memorial for paratroopers dedicated at Miramar @VANatCemeteries https://t.co/E15jycKj5X via @sdut
Are you on LinkedIn? Be sure to follow Rice University! https://t.co/aZqRiSLgYI
MD Anderson Cancer Center@MDAndersonNews
“#Lynchsyndrome is seriously underdiagnosed.” Learn how one of our doctors is helping raise awareness for a genetic syndrome that increases #cancer risk: https://t.co/yTyF65p0Zr #endcancer https://t.co/70Ok973o84
From baldness & infertility to high blood pressure & increased risk of heart attack, the side effects of steroid use may have a more serious health impacts than you thought.
Legacy project to tell the stories of Veterans interred at Riverside @VANatCemeteries https://t.co/Tu7MCotplc via #VAntagePoint
RT @culturemap: Medical Center's magical Match Day means start of Houstonians' dreams https://t.co/thisTyCaGe
RT @UTCVSurgery: Dr. Tom Nguyen Awarded First Place for #ACC’s Transcatheter Heart Valve Handbook! Read more here: https://t.co/P9Vz8iq6wi
RT @UTCVSurgery: Have you registered for The Inaugural Houston AFib Patient Experience Seminar yet? Read more here: https://t.co/Z0a8ftrol…
The Hurricane Harvey Relief Fund has awarded $2.6 million to The University of Texas Health Science Center at Houston (UTHealth) for a technology-supported program for patients with unmet post-Harvey behavioral health needs.
University of Houston@UHouston
@ohnosydneylo It’s perfect! https://t.co/A7jp3WeclR
U.S. Department of Veterans AffairsVeteransAffairs
Today's #VeteranOfTheDay is Army Veteran Les Payne. Les was born July 12, 1941 in Tuscaloosa, Alabama. He received a degree from University of Connecticut in 1964 and went on to serve in the Vietnam War during a tour with the Army. After his time in the military, Les joined Newsday in 1969. Les was part of the Newsday reporting team that created a 33-part series tracking heroin from growth in Turkey to being sold in America. "The Heroin Trail" won a Pulitzer Prize in 1974. Les was a founding member and former president of the National Association of Black Journalists. He retired in 2006, spending nearly four decades at Newsday and setting the standard for excellent journalism. Les died Monday night at his home in Harlem. We honor his service.
Today's #VeteranOfTheDay is @USArmy Veteran Les Payne. Les was a founder and former president of @NABJ, @PulitzerPrizes winner, and long time reporter for @Newsday.